The present study contributes to clarify the mechanism underlying the high efficacy of hepatocyte gene transfer mediated by hydrodynamic injection. Gene transfer experiments were performed employing the hAAT gene, and the efficacy and differential identification in mouse plasma of human transgene versus mouse gene was assessed by ELISA and proteomic procedures, respectively. By applying different experimental strategies such as cumulative doseresponse efficacy, hemodynamic changes reflected by venous pressures, intravital microscopy, and morphological changes established by transmission electron microscopy, we found that: (a) cumulative multiple doses of transgene by hydrodynamic injection are efficient and well tolerated, resulting in therapeutic plasma levels of hAAT; (b) hydrodynamic injection mediates a transient inversion of intrahepatic blood flow, with circulatory stasis for a few minutes mainly in pericentral vein sinusoids; (c) transmission electron microscopy shows hydrodynamic injection to promote massive megafluid endocytic vesicles among hepatocytes around the central vein but not in hepatocytes around the periportal vein. We suggest that the mechanism of hydrodynamic liver gene transfer involves transient inversion of intrahepatic flow, sinusoidal blood stasis, and massive fluid endocytic vesicles in pericentral vein hepatocytes. Gene Therapy (2005) 12, 927-935.
Introduction
The liver is a large and extremely complex gland with a great variety of functions, including bile formation, the metabolism of carbohydrate, fat and proteins, and blood filtration. With the exception of gammaglobulins produced by lymphoid tissue plasma cells, all plasma proteins are formed by hepatocytes. Thus, albumin (Alb), alpha-1-antitrypsin, fibrinogen, coagulation factors, and some other proteins are synthesized in the rough endoplasmic reticulum of hepatocytes, transported to the cell surface via the Golgi apparatus, and secreted into the bloodstream. As many disorders of liver metabolism are caused by monogenic defects, the liver should be considered as an important target organ for gene therapy;
1-2 the development of safe and efficient procedures for liver gene delivery constitutes a crucial step in this sense. Since naked DNA is the simplest and safest gene delivery system, 3 multiple approaches have been attempted for in vivo liver gene delivery, including intraportal injection, 4 increased DNA retention time in the liver, 5 electrogene transfer, 6 hydrodynamic i.v. injection, 7, 8 and mechanical liver massage. 9 However, hydrodynamic transfection has become widely used 10 because of its simplicity and high efficiency. By employing this procedure, high efficiencies of human alpha-1 antitrypsin gene transfer have been described, 11,12 and recently we have been able to demonstrate 13 that long-term therapeutic levels of human alpha-1-antitrypsin in mouse plasma can be achieved by this procedure.
The important efficacy of nonviral DNA gene delivery mediated by hydrodynamic injection opens new perspectives for future safe applications in liver gene therapy. Tolerance to cumulative multiple doses is an important advantage for clinical practice, but the efficacy and tolerance to cumulative transgene dose employing the hydrodynamic procedure is poorly known yet. In addition, the procedure has serious limitations for application in clinical practice, and further improvement of the technique requires elucidation of the mechanism underlying the high efficacy of gene transfer -with the aim of combining the mechanistic principle of hydrodynamic injection with established medical procedures. In this sense, it has recently been suggested that increased pressure in the liver microcirculation produces transient (5-10 min) membrane defects 14 or pores 15 through which naked DNA can penetrate the liver cells through simple diffusion. However, the exact mechanism by which the hepatocyte membrane remains permeable for several minutes, allowing DNA to cross the cell membrane without causing cell death, due to ruptured intracellular ionic homeostasis, remains to be clarified.
In the present work, we show good mouse tolerance and efficacy of cumulative hydrodynamic doses of hAAT gene. In addition, employing different experimental strategies such as differential venous pressures, intravital microscopic observation of intrahepatic blood circulation, and transmission electron microscopy, we suggest the mechanism of hydrodynamic liver gene transfer to involve transient inversion of intrahepatic flow, sinusoidal blood stasis, and massive fluid endocytic vesicles in hepatocytes distributed around the central vein.
Results

Efficacy of hydrodynamic gene transfer: cumulative doses
Groups of mice (n ¼ 5) were treated every 15 days with increasing dose of pTG7101 plasmid (0.3, 0.9, 3.7, 5, 10, 20, 40, and 80 mg), resulting in a final cumulative dose of 0.3, 1.2, 5, 10, 20, 40, 80, and 160 mg/mouse. The treatment was well tolerated and amount of hAAT in plasma, as a function of the injected plasmid-gene molecules resulted ( Figure 1 ) in a good dose-response curve (R ¼ 0.98), with an Emax 3258 mg/ml and EC 50 1.84 Â 10 12 plasmidic gene units. The efficacy and good mouse tolerance of eight hydrodynamic cumulated doses strongly support that hydrodynamic gene transfer could be applicable for clinic, provided that clinically unacceptable hemodynamic effects induced by the procedure could be circumvented.
Liver toxicity of hydrodynamic cumulative dose
To evaluate potential liver injury mediated by hydrodynamic procedure, we have performed two independent experiments employing single or cumulative doses. In the first case, five mice were hydrodynamically injected with a single 20 mg dose of pTG7101 plasmid, and then blood tail vein samples were obtained on days 1, 2, and 7 after injection. In the second experiment, five mice received eight hydrodynamic injections spaced 2 weeks apart and increasing the DNA dose from 0.3 to 80 mg of plasmid (experiment in Figure 1 ). Blood samples from tail vein were obtained on days 10-12 after each injection. In all cases, aliquots of plasma from the five mice were pooled and analyzed to evaluate the effect of treatment on the plasma levels of Alb, alanine aminotransferase (ALT), aspartate aminotransferase (AST), g-glutamyl transferase (GGT) and alkaline phosphatase (ALP). The results are expressed as the mean value of duplicates with 5% lower differences. The data presented in Table 1 indicate that simple hydrodynamic injection (Table 1a) increases ALT and AST values on days 1 and 2 after injection, and only AST remains elevated on 7 day. However, all other parameters remained at normal plasma levels. Interestingly, no signs of liver injury were observed after cumulative hydrodynamic injections (Table 1b) , since the above indicated parameters remained unaltered at all times.
Differential venous pressures between portal and inferior cava veins
Hydrodynamic injection was performed through the left femoral vein (draining into the inferior cava), and simultaneous portal and inferior cava vein pressures were monitored by placing respective catheters into a mesenteric vein and the right femoral vein. Figure 2 shows both portal and inferior cava venous pressure recordings after hydrodynamic injection of a representative experiment. In both cases, the highest pressure (20-30 mmHg) was observed immediately after injection, suggesting that either the liver sinusoids do not offer significant hydrodynamic resistance, or some venous shunts intervened. However, the maximal venous pressures were inverted, since maximal pressure was observed in the inferior cava. Figure 3 shows the mean For correct blood flow, this value should be positive, though in our study we observed negative values for a few minutes after hydrodynamic injection -with a maximum negative value of À2.0 mmHg, suggesting that retrodynamic blood flow to the liver is possible. That is a relevant data because it gives experimental support to the retrodynamic blood flow hypothesis. In this respect, negative pressure difference between portal vein and inferior cava vein could be expected because the hydrodynamic injected solution enters the liver from the central vein but it has not been previously confirmed.
In addition, increased pressure of inferior cava vein is a necessary but not sufficient condition for pressure inversion since vascular hepatic resistance could facilitate early opening of porto-cava vein shunts, resulting in simultaneous increases of both portal and cava vein pressures.
Intravital microscopy of liver circulation
The aim of these experiments was to study whether the above-mentioned venous pressure inversion between the portal and inferior cava veins after hydrodynamic injection could result in inverted hemodynamic flow into the liver. The results are summarized in Figure 4 , where the vascular tree (dark) and liver parenchyma (light) is easily distinguished. First, we see that good vascular flow was present before hydrodynamic injection (0 min). In Figure 5 , the arrows indicate the main sinusoids in which a net flow from portal to central vein can be observed, though neither sinusoid was without blood flow. Second, at the time of hydrodynamic injection, the flow progressively stopped, the diameter of the central vein increased, and the hemodynamic flow was inverted for 5-10 s, after which total liver flow (sinusoids and the large efferent central veins) was stopped. The figure shows (1 min after hydrodynamic injection) reinforcement of the sinusoids (dark), while the double arrow indicates the increased venous diameter. Third, liver circulation recovered very slowly, starting in the larger veins and then the sinusoids. As it can be seen in the figure, 3 min after injection, approximately 5% of Mechanism of hydrodynamic liver gene transfer A Crespo et al sinusoidal flow had recovered (arrows). Finally, after 6 min, 95% of sinusoidal flow had been restored, and only a few sinusoids remained without blood flow (white star in the figure).
Transmission electron microscopy: hepatocyte morphological changes
Hepatocyte gene transfer mediated by hydrodynamic injection is a rapid process, and consequently the corresponding morphological changes must be mainly observed in the initial period following injection. For this reason, glutaraldehyde was hydrodynamically injected to avoid the tissue fixation time delay due to low fixer diffusion. On comparing liver tissue without or with hydrodynamic injection (Figure 5 ), several morphological changes should be pointed out: (a) the quasivirtual vascular lumen in the untreated mouse was greatly increased (five-to 20-fold) after hydrodynamic injection; (b) the subendothelial space between the endothelial cells and hepatocytes (ie, the Disse space) was also increased after hydrodynamic injection; and (c) massive fluid endocytic vesicles were observed in the hepatocytes of hydrodynamically injected mice and, moreover, many endocytic vesicles were several times greater in diameter than in the case of untreated mice. On the other hand, it should be mentioned that the morphological changes were differentially distributed within the liver, and were mainly observed ( Figure 6 ) in the pericentral vein areawith few changes in the periportal territory. In no case, hepatocyte plasma membrane disruption was observed.
Discussion
As hydrodynamic gene transfer is the principal nonviral procedure for in vivo liver gene transfer, the present work aimed to contribute to clarify the tolerance and efficacy of cumulative doses as well as the mechanism underlying the hAAT gene delivery process mediated by this technique. The results obtained indicate that: (a) therapeutic plasma levels of hAAT can be achieved with good mouse tolerance employing cumulative dose; (b) hydrodynamic injection mediates the inversion of vein pressure between portal and central vein, supporting the possibility of retrodynamic blood flow; (c) the intravital observations show that hydrodynamic injection mediates transient intrahepatic flow inversion, with blood stasis lasting a few minutes, mainly in the sinusoids around the central veins; and (d) transmission electron microscopy shows hydrodynamic injection to promote massive fluid endocytosis in hepatocytes distributed around the central vein but not around the periportal vein. Recently, we have described 13 that increased plasma levels of hAAT can be observed in a dose-dependent response by hydrodynamic injection of single doses of pTG7101 plasmid, employing independent animal groups per dose. Since the procedure can mediate liver Figure 4 Intravital microscopy of liver blood flow. The in vivo observation of mouse liver blood flow was performed using an inverted microscope with a 20-fold objective, and the images were recorded using a S-VHS video system. Mice were hydrodynamically injected into the left femoral vein, and digitalized images of the same microscopic field are shown at different time periods: before injection (0 min) and 1, 3, and 6 min after injection. Single arrow indicates the direction of blood flow, while double arrow shows the increase in vein diameter after hydrodynamic injection. The differences in sinusoidal flow are easily identified because the light vascular tree observed at 0 min contrasts with the dark vascular tree after injection. The white star indicates the sinusoids in which blood flow remain stopped 6 min after injection.
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A Crespo et al injury that could limit the efficacy of repetitive administrations, we wished to study the effect of multiple dose administration in a cumulative mode. Since maximal plasma levels of hAAT are achieved 12-15 days after hydrodynamic injection of pTG7101 plasmid, the individual doses were administered every 15 days. Previously, a blood sample was taken to measure hAAT in plasma. Treatment was well tolerated, as shown by long-term mice survival, and because multiple doses did not modify the efficacy of gene transfer, suggesting that liver injury induced by hydrodynamic injection was transient and not serious. The low toxicity is also supported by the fact that no changes in biochemical parameters related to liver injury were observed during the eight cumulative doses of hydrodynamic treatment.
In addition, transgenic hAAT protein was identified in mouse plasma by proteomic techniques. Although ELISA is a well-established method to estimate the level of hAAT gene expression in transfected animals, the possibility of this procedure to reach the clinical application allows additional control tests to contribute to guarantee the quality of the method. The fact that we found, by MALDI-TOF mass spectrometry, two homologous peptides for mouse (fragment 113-143 at m/z 3498.9) and human (fragment 121-153 at m/z 3665.9) in the same spectrum and displaying similar intensities (data not shown), strongly suggests that mouse and human alpha-1-antitrypsin proteins are expressed in similar amounts in the plasma of mice transfected with pTG-7101 plasmid. 
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The liver receives a profuse blood supply from the hepatic artery and portal vein. The hepatic artery is relatively small and supplies oxygenated blood, while the portal vein transports venous blood from the gastrointestinal tract. Blood leaves the liver through hepatic veins that drain into the inferior cava vein. Thus, venous flow from portal vein to inferior cava must cross the liver parenchyma through the hepatic sinusoids. As it has been described that hydrodynamic transfection mediates transgene expression by hepatocytes mainly located around the pericentral vein but not the periportal vein, 11,13 it has been suggested 13, 15 that retrograde blood flow in the liver should be possible, since hydrodynamic tail vein injection drains into the inferior cava. However, no previous studies have been made to evaluate whether the retrograde flow hypothesis is supported by the inversion of venous pressure between the portal vein and inferior cava. It has recently been described 15 that hydrodynamic injection greatly increases the pressure of the inferior cava vein, but no simultaneous pressure measurements of the portal vein were recorded in those experiments. Thus, it remains to be clarified if intrahepatic vascular resistance could facilitate early opening of porto-cava vein shunts, resulting in simultaneous increases of both portal and cava vein pressures. The rapid increase in both the inferior cava and portal vein pressures observed after hydrodynamic injection suggests the opening of porto-cava vein shunts, but we must underline that pressure in the inferior cava vein remains higher for at least 5 min, thus supporting that an inversion in blood flow is hemodynamically possible for this period of time. In addition, the intravital 
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A Crespo et al microscopy indicates that an inverted sinusoidal flow from central to portal vein can be observed in the first 5-10 s of injection, after which intrahepatic flow is stopped for approximately 1 min, and finally normal flow from portal to central vein is progressively restored over the subsequent few minutes. The last flow to be restored corresponds to the sinusoids around central vein areas. This observation is particularly interesting, since after hydrodynamic injection transgene expression is also mainly identified by immunohistochemical procedures 13 on hepatocytes distributed around central vein areas. It has been described 15 that gene transfer facilitated by hydrodynamic injection remains for a few minutes (10-15 min) after injection. Although the highest gene transfer efficacy with this procedure has been observed by simultaneous administration of gene in a large volume, this is not a necessary condition, because when gene is administered in low volume, a few minutes after irrelevant hydrodynamic injection of a saline solution without DNA, good gene transfer efficacy is also observed, thus suggesting that anatomical changes should persist for a short time period. To observe the possible liver morphological changes after hydrodynamic injection, an ultrastructural electron microscopic study was made. We first compared the morphological changes between livers from control mice (fixed by the classical procedure) versus mice hydrodynamically injected with 2.5% glutaraldehyde. As the i.v. administration of fixer avoids the tissue fixation time delay due to low diffusion of fixer, we expected to be able to observe the early morphological changes associated with hydrodynamic injection. As expected, the diameters of venous vessels from hydrodynamically injected mice were greatly increased, endothelial discontinuity was increased in many places, and the virtual Disse space between the endothelium and hepatocytes was also increased. However, the most evident liver change was massive fluid endocytic vesicles observed in many hepatocytes and the large diameter of the endocytic vesicles (several times larger than normally observed). Thus, the classically described microfluid uptake process appears to be transformed into a megafluid endocytic process, which must contribute to increase the cytoplasmic volume or pressure. This could facilitate hepatocyte gene delivery, since it has been reported 15 that gene expression efficacy mediated by cytoplasmic microinjection of a same copy number of gene plasmid is increased when large volumes are used for injection. We do not know the mechanism of gene escape into the cytoplasm, though our observations agree with previous suggestions that a diffusion process with low hepatocyte toxicity is involved, mainly since eight cumulative hydrodynamic doses have been well tolerated. Although it has been hypothesized 16 that naked plasmid DNA is taken up by cells in vivo via a receptor-mediated mechanism, recent studies 15, 17, 18 and our own observations (data not shown) suggest a nonspecific nature of the hydrodynamic delivery process. Recently, it has been proposed 15 that plasma membrane pores, generated by aqueous solution after hydrodynamic injection, may allow direct entry of DNA or other substances into the cytoplasm for a few minutes, after which membrane resealing processes may occur. The large pore diameter suggested for DNA delivery should limit the cell viability and mediate a more relevant cell toxicity but certainly this does not occur. Now, we suggest that if such DNA penetration into hepatocytes is via simple diffusion, it could take place through permeabilized sites in the large endocytic vesicles -although we have failed to find plasma membrane disruptions. This suggestion successfully combines DNA diffusion through the plasma membrane and low hepatocyte toxicity, because the endocytic vesicles could limit the loss of essential cytoplasm components. In addition, the hypothesis explains why the liver is the principal target organ for gene transfer, since hydrodynamic injection could greatly amplify the natural ability of hepatocytes for microfluid endocytosis. The preferential pericentral vein gene transfer efficacy could be due to the fact that sinusoids connected with pericentral veins are stressed to high pressures versus distant and tortuous sinusoids around portal veins. Such high pressure should mediate the formation of massive endocytic vesicles, increasing the cytoplasmic volume/ pressure to a critical point that successfully increases gene nuclear availability, resulting in immunohistochemically detectable cells producing the transgene around pericentral veins. Additional studies will be necessary to confirm this suggestion and to clarify the exact mechanism underlying DNA crossing of the plasma membrane. 
Materials and methods
Reagents
Goat anti-hAAT antibodies (nonconjugated and peroxidase conjugated) were obtained from Sigma (SIGMA Chemical Co., Spain). pTG7101 is a plasmid containing the full length of the human AAT. The plasmid was a generous gift from Dr P Meulien and Dr JP Lecocq (Transgène S.A., Strasbourg, France). The TG7101-18.6 kb plasmid employed in the present work contains a 16.5 kb genomic fragment of hAAT gene, cloned in SalI site of Poly III-I plasmid. In addition, it contains a 1.8 kb genome sequence upstream promoter, the promoter and full length of human AAT gene, and 3.2 kb downstream gene.
In vivo gene transfer C57BL/6 mice (n ¼ 5 per group) were hydrodynamically injected into the tail vein with a volume of saline solution equivalent to 10% of body weight in 5 s, containing different amounts of plasmid DNA, using a 3-ml latexfree syringe (Beckton Dickinson). Over a period of 3.5 months, each mouse received a total of eight hydrodynamic injections (one injection every 15 days, for a total of eight runs) containing 0.3, 0.9, 3.7, 5, 10, 20, 40, and 80 mg of pTG7101 plasmid, respectively. Blood samples (200 ml) were taken from the tail vein on days 10-12 after transfection, using heparinized glass capillaries. After centrifugation, plasma was recovered and a pool was obtained mixing 50 ml/mouse for each group.
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The plasma samples were inactivated (551C, 45 min), centrifuged (20 000 g, 15 min) and kept at À201C until ELISA assay or biochemistry of liver injury parameters.
Measurement of venous pressure
Following anesthesia, the abdomen was opened by a midline incision and a catheter was inserted into a mesenteric vein to record the portal vein pressure. Two additional catheters were inserted into the right and left femoral veins to record the pressure in the inferior cava vein territory and for hydrodynamic injection, respectively. Catheters were previously heparinized and then filled with saline solution. The venous pressures were continuously monitored employing a Spectramed Statham pressure transducer (model P23XL) and a Grass model 7 polygraph (preamplifier model 7P1J and amplifier model 7DAG).
Intravital microscopy
Mice weighing 20 g were anesthetized and a catheter was introduced into the left femoral vein. A midline laparotomy was performed, followed by careful mobilization of a liver lobule without disturbing the hepatic circulation. The animals were placed on a universal glass slide support and positioned on their left side. This positioning allowed partial luxation of the mobilized liver lobule, which was placed and held on the adjacent slide employing a humidified filter paper to avoid liver drying and movement artifacts caused by heart beats or ventilation. For intravital observation, an inverted Zeiss microscope (Axiovert 135M) was used containing a 20-fold objective under the glass slide. The microscope was connected to a video enhancer-zoom lens system and a color CCD-video camera (Sony SVT-S3050P) allowing real-time imaging via a separate monitor. Images were recorded using a timer-equipped S-VSH video system (Sony SVT-S 3050P) for further analysis. In a typical experiment, mice were hydrodynamically injected into the femoral vein with 2 ml of saline solution in 5 s, containing 40 mg of pTG7101 DNA plasmid, and the intrahepatic hemodynamic changes were recorded for at least 10-15 min.
Transmission electron microscopy
Livers were obtained from anesthetized mice (20 g weight). Small tissue pieces were immersed in phosphate Sørensen buffer (pH 7.4) solution containing 2.5% glutaraldehyde. Some animals were previously treated by hydrodynamic injected via tail vein with 2 ml of 2.5% glutaraldehyde. Posteriorly, multiple 1-mm 3 pieces of liver were routinely processed for transmission electron microscopy and embedded in Epon resin. Semithin sections (1 mm), stained with toluidine blue, were evaluated by light microscopy. Ultrathin sections, stained with uranyl acetate and lead citrate, were examined under a Philips 300 electron microscope.
